Skip to content
Home/Companies/Biotech/Alia Therapeutics
AT

Alia Therapeutics

Biotech·Italy·Active·5yr hold

Alia Therapeutics is a healthcare / biotech company, headquartered in Italy.

Entry
2021
Hold
5yr
Status
Active
Est. EV
–

Who owns Alia Therapeutics?

Alia Therapeutics is currently owned by Sofinnova Partners through Sofinnova Telethon (2016 vintage), since 2021.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Telethon · 2016 · Life Sciences VC

Key facts

HQItaly
SectorHealthcare / Biotech

More from Sofinnova Telethon

Other portfolio companies in the same fund.

nChroma (formerly Chroma Medicine)
Active
BiotechUS· 2022
Nephris
Active
BiotechItaly· 2022
Borea Therapeutics
Active
BiotechItaly· 2021
AAVantgarde Bio
Active
BiotechItaly· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings